chrisvoncsefalvay/vaers-outcomes huggingface dataset:
QUAD FLU VAC GIVEN AT PRIMARY DR OFC. Thought the next week soreness would be expected, then became unbearable stab like pain where injection was given, I was unable to lift my arm above chest level, unable to sleep with severe pain. I got an appointment with out of network ortho doc thru recommendation to avoid any type of cover up. It a few weeks to get in with him. On 11/22 had xrays, exam and steroid inj. into the same site was performed. He had suspected SIRVA at that time. I had about 10 14 day relief. The pain came back with a vengeance. Saw him again 12/14/17. PE another injection and Rx for PT. Did 6 months of PT hitting plateau, though got most of range of motion back, I still have pain. I did do 5 acupuncture visits to help with the pain from 3/23/18 to 5/11/18. It did give some relief. Pt told me to have follow up with Dr. MRI was performed, and follow up with him was done 7/11/18. He told me to report this to CDC as I still have pain. I have also spent a lot of $ with all co-pays.
Hardness at injection site, High pitched screaming, Sleepiness, Fever, Loss of ability to rollover, (later that day) restlessness, sleep disturbances and respiratory infection.
Got the first HPV vaccine on Friday 6/17/22.  Developed bodyaches and subjective fever about 4 hours after the shot.  Developed headache 4 days after vaccine.  She took ibuprofen and used heating pad for bodyaches.  Mild soreness, swelling, redness at the site of injection right deltoid the first 3 days and resolved on day 4.
Intense body aches, chills, headache and racing heart / heart palpitations. All symptoms lasted for approximately 36 hours.
pt broke out in chickenpox 17FEB98;pox on face legs head & groin;s/s itching & spreading;
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date during 2015, the patient was inoculated at a pharmacy with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On an unknown date during June 2016, the patient was treated by a physician for a severe vesicular outbreak, which was diagnosed as herpes zoster, or shingles. The patient was prescribed valacyclovir and gabapentin for management of her painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events is unknown.  Additional information has been requested.
This is a spontaneous report from a Pfizer sponsored program.  A contactable physician (patient, reported a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration on 13Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 for covid-19 immunisation. She got the second dose of the Covid19 vaccine last 13Feb2021 and then Monday she was having back ache in Feb2021. Until now she was still experiencing mid back (as reported). The outcome of the event was not recovered.  Follow-up attempts are completed. Information about lot/ batch number cannot be obtained.
This case was reported by a grandfather of a consumer and described the occurrence of wrong vaccine administration in a 2-month-old female subject who was vaccinated with (BOOSTRIX, GlaxoSmithKline). A physician or other health care professional has not verified this report. On 12 December 2008 the subject inadvertently received a dose of BOOSTRIX at 0.5 ml in the right thigh. This was the wrong vaccine. The subject should have received INFANRIX. The child was taken to the hospital several days later due to cough and cold. At the time of reporting the outcome of the events was unspecified.
(L) leg swelling, redness, hives x 2 episodes 2-3-11 vaccine, 4-5-11 vaccine.
Patient with swelling and pain in right upper arm from pneumococcal polysaccharide PPSV23 shot given on 9/22. Patient states that after injection on Friday, he developed fever of 101.0, shaking chills, pain at site of injection. Patient denies fever or chills today (09/25/2017) during phone f/u but does have redness and swelling of injection site. Myalgia, fever and right arm swollen and sore. Acetaminophen 650 mg prn.
pt recv vax & devel an inj site rxn;no further info was available @ the date of this report;reporter indicates that about a dozen pt exp this event;however, they are not presently identifiable;addtl reports will be generated;
Slight headache; Heart racing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 11Mar2021 (Lot number: EN6208) at the age of 70 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Allergy" (unspecified if ongoing), notes: Known allergies: Yes; "Hypothyroidism" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "congestive heart failure" (unspecified if ongoing); "Allergic history to medications, food, or other products" (unspecified if ongoing); "Allergic history to medications, food, or other products" (unspecified if ongoing). Concomitant medication(s) included: LOSARTAN; SPIRONOLACTONE. The following information was reported: HEADACHE (non-serious) with onset 11Mar2021 16:30, outcome "not recovered", described as "Slight headache"; PALPITATIONS (non-serious) with onset 11Mar2021 16:30, outcome "not recovered", described as "Heart racing". Therapeutic measures were not taken as a result of headache, palpitations.  Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. It was reported that within fifteen minutes of the receiving the first vaccine ae occurred. Through the month, medical conditions got worse. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  No follow-up attempts are possible. No further information is expected.
Patient started to feel nauseous, weak, and spiked a fever of 101.4 degrees F today day after vaccine.He is still experiencing these symptoms. Advised patient to rest, hydrate, and take Tylenol for the fever if safe and appropriate.
Onset of fatigue and mild nausea at 7:00 PM, headache started around 8:00 PM, developed severe chills around 9:00 PM that lasted until development of fever around 10:30/11:00 PM. Fever currently persists as of now (12:06 AM)
RED, BLISTER TOP SORE.   USED HYDROCORTISONE WITH NO CHANGE F0R 3 DAYS, NOW NO BLISTER, BUT SKIN STILL RED AND DRY
Narrative:  76yo male died in hospice care with Medical Diagnosis: Other Frontotemporal Dementia on 7/8/2022. Pt had received a covid J&J vaccine EUA on 4/28/2021. Likely this death is not related to the vaccine given hospice care at end of life and lont time between date of vaccine and date of death.
Vaccine received on Aug 30, 2010 and redness (L) deltoid. Aug 31, swelling, hot, itchy, fever - 09/01/2010 - decreased swelling still hot and itchy - loratadine and ADVIL on Aug 31.
Joints became sore and right foot very tight the night following shot (4/3/2021).  Pain continued to build following day (4/3/2021 aka Easter).  By 9:30 PM on the night of 4/3 the large right toe had swollen and was unable to move.  By the morning of 4/4/2021 no pressure could be placed on the right foot without extreme pain.  Pain reached highest pain by 4/7/2021 and has slowly tapered but remains.  Swelling has reduced to point where a lose shoe can be placed over foot and some walking can occur with effort.   Joint pain continues in shoulders, knees and hips.  I become winded after walking only a few hundred feet.  (typically jog 2 miles/day and walk an additional 5 miles)
Three reactions: 1) Facial flushing extending to about 2 inches down the neck. Some facial swelling. Noticeable to vaccine recipient visibly and by sensation of heat 30 minutes following injection; subsided in approximately 4 hours. Put car fans on maximum cool and aimed at face. Sensation of being overheated went away in 15 minutes. Redness went away in approx. 4 hours. 2) Pain at injection site - lasted about 36 hours 3) Flu symptoms - fever, chills, body aches, joint pain, extreme tiredness - began about 4 hours after injection, lasted approximately 36 hours. I did not seek medical help.
WHOLE BODY SHAKING; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced whole body shaking. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of whole body shaking was not reported. This report was non-serious. This case, from the same reporter is linked to 20220146346 and 20220147068.; Sender's Comments: V0; Medical assessment comment not required as per standard procedure as case assessed as non-serious.
Information has been received from a registered nurse referring to a patient of unknown age and gender. Information about medical history and concurrent condition was not reported. On 19-MAR-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K003520 with expiration date of 20-NOV-2016; dosage and route unspecified) (incorrect product storage). No adverse symptoms were reported. This is one of several reports received from the same reporter. Additional information has been requested.
about 3 hrs later threw up 3 times, and has elevated pulse of 116, its usually 78, next morning woke up feeling a bit weak and light headed.  We are thinking maybe its a combination of the vaccine plus that he ate tamales that evening that may have prompted the vomiting.  Seems a bit better today, no vomitting but feels weak and pulse is high.  Tried to make an appt tp see  hisDr but they wont see him for 14 days cause he thre up. He is 92 and can not do a virual appt.!!!
had the shots, had shingles / Suspected vaccination failure; had shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: had the shots, had shingles / Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: had shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 28-APR-2023 Reporter's comment: This case was reported by a patient via interactive digital media. The patient had the Shingles shots and had shingles since Christmas.  Things work to awhile and then he or she try something else.  Now rotating several treatments. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow up would not possible as no contact details were available.
This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 70-year-old female patient who received SHINGRIX for prophylaxis. On 21st May 2018, the patient received the 1st dose of SHINGRIX (intramuscular) 50 mcg/mg. In May 2018, less than a week after receiving SHINGRIX, the patient experienced injection site erythema, heartbeats increased, vomiting, diarrhea, injection site swelling and injection site itching. On an unknown date, the outcome of the injection site erythema, heartbeats increased, vomiting, diarrhea, injection site swelling and injection site itching were recovered/resolved. It was unknown if the reporter considered the injection site erythema, heartbeats increased, vomiting, diarrhea, injection site swelling and injection site itching to be related to SHINGRIX. Additional details were provided as follows: The patient was administered SHINGRIX in the left arm. The patient experienced redness, swelling and itching at the injection site which was 4 by 4 inches in diameter. This lasted for about total of 2 weeks. On the sixth day after getting the vaccine the patient woke up in the middle of night and had vomiting, diarrhea and fast heart beat which lasted for total of 3 hours. The patient called to ask if she should get the second shot since she experienced adverse reactions with the first shot. The patient had denied permission to contact their physician. No further details were provided by the patient.
Muscle cramping below sternum into the back around 1:00 AM in 3/20/21. The pain made me restless and never stopped, like a permanent cramp. Attempting a foam roller to stretch my muscle and release some pin to no luck. I considered going to the ER because of the pain not subsiding.   Around 2:30 AM I started throwing up, which lasted off an on for about a hour.   I returned to bed around 3:30 AM with the muscle tightness still happening. Around 4:00 I began having chills and my muscle started to relax. By 5:00 AM I was sleeping. No ongoing effective expect fatigue, and my throat was sore from throwing up.
Within 10 days of MMR vaccine patient had fever of 103.0 and a rash all over his body. Patient was developing normally until the shot and within days of receiving the vaccine developed Autistic like symptoms. We are currently in the process of receiving an Autistic diagnoses.
Temp of 105.5 about 6 hrs after vaccination. Defervesced with TYLENOL & MOTRIN after 14 hours. Inconsolable cry with elevated temp. fussy but improved with normal temp. At time of report afebrile but fussy still.
This spontaneous report was received from a healthcare worker and refers to unspecified patients of unknown age and gender. The patient's pertinent medical history and concurrent conditions were not reported. No previous drug reactions or allergies were reported. On an unknown date the patients were vaccinated with improperly stored VARIVAX (Merck) (strength, dose, frequency and route were not reported) lot # K021933 with an expiry date of 17-SEP-2016 and lot # L004649 with an expiry date of 11-FEB-2017. No concomitant medications were reported. Patient did not seek any medical attention. No adverse effects were reported. There was no product quality complaint. This is one of the several reports received from the same reporter. Additional information has been requested.
Information was received from a lawyer on 16-APR-2019 regarding a case in litigation, concerning a female patient who on an unknown date was inoculated with ZOSTAVAX for routine health maintenance and for its intended purpose the prevention of shingles (herpes zoster). On an unknown date the patent suffered sensations of burning, tingling, and sudden sharp localized pains accompanied by a rash. As a result of her symptoms, patient presented to a medical provider and was ultimately diagnosed with shingles. As a direct and proximate result of ZOSTAVAX the patient's symptoms have resulted in physical limitations not present prior to using the product. Patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result the patient sustained severe and permanent personal injuries and serious progressive, permanent and incurable injuries as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. Shingles was determined to be disabling. Additional information has been requested.
I remained sick for 4 or 5 days.  I had fever, fatigue, headache and head congestion within the first 2 days. I called my doctor and she arranged for me to see a telehealth appointment with another provider. She prescriber Molnupiravir and Benzonatate which I began take on December 31, 2022, t took 3 weeks for a test to be negative.
I did not have an adverse reaction to the vaccine. I developed symptoms of a yeast infection. I went to my doctor and was diagnosed strep infection and I was put on antibiotics. The infection returned and I had to take antibiotics for 10 days. As of today, I am feeling better with no side effects.
Started with arm pain, then lymph nodes in armpit were swollen and arm pain increased, could barely move arm because of pain, nausea and vomiting, chills and fever of 100.9, injection site the size of a baseball almost 48 hours after injection, super fatigued
Patient described red rash with inflammation from injection site to elbow and back around tricep area. Lasted for about 3 weeks.
She suffered from headaches prior to the booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 07Apr2021 (Lot number: ER8735) at the age of 67 years as dose 2, single and administration date 10Mar2021 (Lot number: EN6205) as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLU.  The following information was reported: HEADACHE (non-serious) with onset 2021, outcome "not recovered", described as "She suffered from headaches prior to the booster".  Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a physician refers to a male patient of unknown age. On 27-OCT-2014 the patient was vaccinated with a third dose of GARDASIL (dose, route, lot# and expiration date not reported). Physician reported that the patient received his first dose of GARDASIL on 17-OCT-2013 and the second dose on 31-JAN-2014. No adverse experience reported. Additional information has been requested.
I received the Senior Flu vaccination Nov. 3rd. Pain began before bed and intensified extremely. Pain may be muscular? All of left shoulder and like a band of pain around upper left arm, to the extreme of being unable to lift my arm from my side. It has eased 9 days following, but pain is still noticeably there.
event 1. dry eyes and eye squinting treatment1.1: Loteprednol Etabonate.  treatment1.1 period: 5/24-5/31 outcomes: stopped using it due to feeling heavy in eye lid  treatment 1.2: Xiidra treatment 1.2 period: 5/12-7/4 outcomes: stopped using it due to no effects and lots of side effects treatment 1.3: punctual plugs treatment 1.3 period: inserted on 5/12 outcomes: no obvious effect treatment 1.4 doxycycline treatment 1.4 period: 6/25-7/3 outcomes: stopped using it because of dry mouth  2. sucking and fish-like movements of the mouth, facial twitching,  difficulty to drive since I can hardly open my eyes while driving, difficulty to do daily activities. suspect Meige syndrome No treatment yet
Fever, difficulty breathing, body aches mostly trunk, headache, red at injection 3? diameter painful
Chills; fever; nausea; headache; body aches; This is a spontaneous report from a contactable nurse (patient). A 25-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), intramuscular on 14Jan2021 13:00 at a single dose on left arm for COVID-19 immunization. The patient medical history was not reported. No allergies to medications, food, or other products. Concomitant medication included linaclotide (LINZESS). The patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), intramuscular on 26Dec2020, 11:00 AM at a single dose on left arm for COVID-19 immunization. The patient experienced chills, fever, nausea, headache, and body aches on 15Jan2021 02:15, after the second dose. No treatment received for the events. The outcome of the events was recovered. The events were considered as non-serious. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was the Hospital. No other vaccines received within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.
Does not remember which arm/ exact date not remembered; it might be heat rash; Rash on the palms of hands, arms, and legs after second shot; Small bump on the skin after second shot; This spontaneous case was reported by a consumer and describes the occurrence of MEMORY IMPAIRMENT (Does not remember which arm/ exact date not remembered), MILIARIA (it might be heat rash), RASH (Rash on the palms of hands, arms, and legs after second shot) and RASH (Small bump on the skin after second shot) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy NOS. Concomitant products included LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL) and HYDROXYZINE for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced RASH (Small bump on the skin after second shot). In April 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (Rash on the palms of hands, arms, and legs after second shot). On an unknown date, the patient experienced MEMORY IMPAIRMENT (Does not remember which arm/ exact date not remembered) and MILIARIA (it might be heat rash). The patient was treated with TRIAMCINOLONE ACETONIDE at a dose of 1 dosage form. In March 2021, RASH (Small bump on the skin after second shot) had resolved. At the time of the report, MEMORY IMPAIRMENT (Does not remember which arm/ exact date not remembered) outcome was unknown and MILIARIA (it might be heat rash) and RASH (Rash on the palms of hands, arms, and legs after second shot) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included Allergy shots scheduled 03 Feb 2021, 17 Feb 2021, 04 Mar 2021, 19 Mar 2021, 05 Apr 2021, then every 2 weeks until 08 Jun 2021 and every 3 weeks thereafter.  On 08 Jul 2021 Patient visited an Allergist, who Prescribed Triamcinolone Acetonide Cream and did not work again patient visited a Dermatologist who has prescribed the same medication.